Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena’s internally discovered and developed drug candidate for weight management, including… (source: Medical News Today)RSS news feeds and Widgets on Feedzilla.com

Leave a Reply